Latest News

Mutant-Allele Tumor Heterogeneity (MATH) in head, neck squamous cell carcinoma patients is effective marker, along with HPV status, of improved patient outcome

Evaluating next-generation sequencing (NGS) data and associated clinical records of head and neck squamous cell carcinoma (HNSCC) patients from several institutions, made available through The Cancer Genome Atlas (TCGA), showed that combining Mutant-Allele Tumor Heterogeneity (MATH) as a biomarker with the patient?s HPV status provides an effective indicator of improved patient outcome, according to research.
View full story

Post your comment.


  • Molecular trigger for cerebral cavernous malformation identified

  • Researchers urge caution in prescribing commonly used drug to treat ADHD

  • Even the elderly can recover from a severe traumatic brain injury

  • Instrument to measure brand embarrassment developed by economists

  • White matter damage caused by 'skunk-like' cannabis, study shows

  • Cognitive behavior therapy can help overcome fear of the dentist

  • How can I tell if they're lying?

  • Amblyopia, not strabismus, identified as key contributor to slow reading in school-age children

  • Visual stress could be a symptom of Chronic Fatigue Syndrome, research suggests

  • Lower availability of omega-3 fatty acids in the body associated with bipolar disorder